Alimera, pSivida eye implant finally wins U.S. approval

September 26, 2014 9:45 PM

19 0

(Reuters) - Alimera Sciences Inc and pSivida Corp said the U.S. Food and Drug Administration approved their vision-loss treatment Iluvien, following three rejections.

Alimera's shares jumped about 16 percent to $5.95, while pSivida rose about 10.5 percent to $4.73 in extended trading.

Read more

To category page